75,411 resources
By Version
By Authority
By Realm
Start Prev Rows 74200 - 74400 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth |
---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.174 | Systolic Blood Pressure_HD_CPT | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.175 | Systolic Blood Pressure_HD_LOINC | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.177 | Diastolic Blood Pressure_HD_SNOMED | active | 2023-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.178 | Diastolic Blood Pressure_HD_CPT | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.179 | Diastolic Blood Pressure_HD_LOINC | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.181 | Remote Blood Pressure_HD_SNOMED | active | 2023-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.183 | Remote Blood Pressure_HD_CPT | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.554 | CABG_Clinical Grouping Condition_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.555 | CABG_Clinical Grouping Condition_HCPCS | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.556 | CABG_Clinical Grouping Condition_ICD10PCS | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.557 | CABG_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.351 | Coronary Artery Disease (CAD)_ICD9 | active | 2023-08 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.352 | Coronary Artery Disease (CAD)_ICD10PCS | active | 2023-08 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.353 | Coronary Artery Disease (CAD)_ICD10CM | active | 2023-08 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.354 | Coronary Artery Disease (CAD)_CPT | active | 2023-08 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.355 | Coronary Artery Disease (CAD)_HCPCS | active | 2023-08 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.356 | Coronary Artery Disease (CAD)_LOINC | active | 2023-08 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.357 | Coronary Artery Disease (CAD)_SNOMED | active | 2023-08 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.358 | Coronary Artery Disease (CAD)_CUI_UMLS | active | 2023-08 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.245 | Chronic Heart Failure (CHF)_ICD9 | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.246 | Chronic Heart Failure (CHF)_ICD10 | active | 2023-11 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.258 | Heart Failure (CHF)_ICD9 | active | 2023-10 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.259 | Heart Failure (CHF)_ICD10 | active | 2023-10 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.260 | Heart Failure (CHF)_SNOMED | active | 2023-10 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.261 | Heart Failure (CHF)_HCPCS | active | 2023-11 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.262 | Heart Failure (CHF)_LOINC | active | 2023-11 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.263 | Heart Failure (CHF)_CPT | active | 2023-11 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.264 | Heart Failure (CHF)_RxNorm | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.585 | COPD_Clinical_Grouping_Condition_ICD9 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.586 | COPD_Clinical_Grouping_Condition_ICD10 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.587 | COPD_Clinical_Grouping_Condition_SNOMED | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.345 | COVID19 Vaccine_CPT | active | 2023-08 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.346 | COVID19 Vaccine_HCPCS | active | 2023-08 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.348 | COVID19 Vaccine_RxNorm | active | 2023-08 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.349 | COVID19 Vaccine_CVX | active | 2025-04 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.291 | CT Colonography_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.292 | CT Colonography_LOINC | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.294 | CT Colonography_Event_Grouping | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.388 | Cardiology _Taxonomy | active | 2023-11 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.333 | Cervical Cytology_HD_CPT | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.334 | Cervical Cytology_HD_HCPCS | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.335 | Cervical Cytology_HD_LOINC | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.336 | Cervical Cytology_HD_SNOMED | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.373 | Cirrhosis_SNOMED | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.374 | Cirrhosis_ICD10 | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.286 | Colectomy_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.288 | Colectomy_ICD9 | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.290 | Colectomy_Event_Grouping | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.305 | Colonoscopy_CPT | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.306 | Colonoscopy_HCPCS | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.307 | Colonoscopy_ICD9 | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.308 | Colonoscopy_SNOMED | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.309 | Colonoscopy_Event_Grouping | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.315 | Colorectal Cancer_HD_ICD10 | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.316 | Colorectal Cancer_HD_ICD9 | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.317 | Colorectal Cancer_HD_SNOMED | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.607 | Diastolic Blood Pressure_Compliant_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.608 | Systolic Blood Pressure_Compliant_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.602 | Contrast induced nephropathy_SNOMED | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.603 | Contrast induced nephropathy_ICD10 | active | 2025-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.604 | Contrast induced nephropathy_Grouping | active | 2025-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.543 | Depression_Clinical Grouping Condition_CPT | active | 2025-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.544 | Depression_Clinical Grouping Condition_HCPCS | active | 2025-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.545 | Depression_Clinical Grouping Condition_ICD10 | active | 2025-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.546 | Depression_Clinical Grouping Condition_ICD9 | active | 2025-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.547 | Depression_Clinical Grouping Condition_LOINC | active | 2025-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.548 | Depression_Clinical Grouping Condition_SNOMED | active | 2025-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.165 | Optometrist and Ophthalmologist Taxonomy HD Taxonomy | active | 2023-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.164 | Diabetic Retinal Screening HD CPT for Tax Pair | active | 2023-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.56 | Diabetic Retinal Screening HD CPT | active | 2024-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.582 | Diastolic Less than 90_HD_Clinical Grouping Event_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.167 | End Stage Renal Disease (ESRD)_HD_SNOMED | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.168 | End Stage Renal Disease (ESRD)_HD_ICD9 | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.169 | End Stage Renal Disease (ESRD)_HD_ICD10 | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.170 | End Stage Renal Disease (ESRD)_HD_HCPCS | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.171 | End Stage Renal Disease (ESRD)_HD_LOINC | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.565 | Essential HTN_HD_Clinical Grouping Condition_ICD10 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.566 | Essential HTN_HD_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.379 | Estrogen Agonists Medications_RXNORM | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.299 | FIT DNA Test_Lab_Grouping | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.295 | FIT DNA_LOINC | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.296 | FIT DNA_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.297 | FIT DNA_HCPCS | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.298 | FIT DNA_SNOMED | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.314 | FOBT Lab Test_Lab_Grouping | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.310 | FOBT Lab_CPT | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.311 | FOBT Lab_HCPCS | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.312 | FOBT Lab_LOINC | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.313 | FOBT Lab_SNOMED | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.244 | Fasting Blood Glucose_Lab_Grouping | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.401 | First Trimester_ICD10 | active | 2024-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.402 | First Trimester_SNOMED | active | 2024-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.403 | First Trimester_LOINC | active | 2024-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.404 | First Trimester_CPT | active | 2024-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.405 | First Trimester_UMLS CUI | active | 2024-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.205 | Bone Marrow Transplant CN_HD_SNOMED | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.206 | Bone Marrow Transplant CN_HD_ICD10 | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.208 | Immunocompromising Conditions CN_HD_ICD9 | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.209 | Immunocompromising Conditions CN_HD_ICD10PCS | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.210 | Immunocompromising Conditions CN_HD_ICD10CM | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.212 | Immunocompromising Conditions CN_HD_SNOMED | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.213 | Cerebrospinal Fluid Leak CN_HD_SNOMED | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.214 | Cerebrospinal Fluid Leak CN_HD_ICD10 | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.216 | Anatomic or Functional Asplenia CN_HD_SNOMED | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.217 | Anatomic or Functional Asplenia CN_HD_ICD9 | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.218 | Anatomic or Functional Asplenia CN_HD_ICD10 | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.220 | Sickle cell Anemia and HB S Disease CN_HD_SNOMED | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.221 | Sickle cell Anemia and HB S Disease CN_HD_ICD10 | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.224 | Pneumococcal Vaccine CN_HD_HCPCS | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.225 | Pneumococcal Vaccine CN_HD_CVX | active | 2025-04 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.226 | Pneumococcal Vaccine CN_HD_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.233 | Cochlear Implant CN_HD_SNOMED | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.234 | Cochlear Implant CN_HD_ICD10 | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.235 | Cochlear Implant CN_HD_HCPCS | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.236 | Cochlear Implant CN_HD_CPT | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.238 | Chemotherapy CN_HD_SNOMED | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.239 | Chemotherapy CN_HD_ICD10 | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.240 | Chemotherapy CN_HD_CPT | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.284 | HDL_LOINC | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.285 | HDL_Lab_Grouping | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.579 | HbA1c Level Less Than 8.0_HD_Clinical Grouping Condition_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.328 | High Risk HPV Test_HD_CPT | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.329 | High Risk HPV Test_HD_HCPCS | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.330 | High Risk HPV Test_HD_LOINC | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.331 | High Risk HPV Test_HD_SNOMED | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.332 | High Risk HPV Test_HD_Grouping | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.337 | Cervical Cytology_HD_Grouping | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.323 | Hysterectomy With No Residual Cervix_HD_CPT | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.324 | Hysterectomy With No Residual Cervix_HD_ICD10 | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.325 | Hysterectomy With No Residual Cervix_HD_ICD9 | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.326 | Hysterectomy With No Residual Cervix_HD_SNOMED | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.327 | Hysterectomy With No Residual Cervix_HD_Grouping | active | 2023-06 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.376 | IVF_SNOMED | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.377 | IVF_HCPCS | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.228 | Influenza Vaccine CN_HD_SNOMED | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.229 | Influenza Vaccine CN_HD_HCPCS | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.230 | Influenza Vaccine CN_HD_CVX | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.231 | Influenza Vaccine CN_HD_CPT | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.367 | Ischemic Vascular Disease (IVD)_SNOMED | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.368 | Ischemic Vascular Disease (IVD)_ICD10 | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.276 | LDL_SNOMED | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.280 | LDL_Lab_Grouping | active | 2023-05 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.194 | Lipid Panel_Event_SNOMED | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.195 | Lipid Panel_Event_HCPCS | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.196 | Lipid Panel_Event_LOINC | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.197 | Lipid Panel_Event_CPT | active | 2023-01 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.517 | Lupus_Clinical_Condition_ICD10 | active | 2025-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.519 | Lupus_Clinical_Condition_SNOMED | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.550 | MI (Myocardial Infarction)_Clinical Grouping Condition_ICD9 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.551 | MI (Myocardial Infarction)_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.552 | MI (Myocardial Infarction)_Clinical Grouping Condition_ICD10 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.370 | Muscular Pain and Disease_SNOMED | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.371 | Muscular Pain and Disease_ICD10 | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.472 | OGTT_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.473 | OGTT_ICD10 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.475 | OGTT_LOINC | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.476 | OGTT_Grouping | active | 2024-08 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.386 | Obesity_Condition_UMLS | active | 2024-04 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.414 | Obesity_Condition_SNOMED | active | 2024-04 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.415 | Obesity_Condition_ICD10 | active | 2024-04 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.416 | Obesity_Condition_ICD9 | active | 2024-04 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.427 | Obesity_Condition_LOINC | active | 2024-04 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.364 | Other Revascularization_SNOMED | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.365 | Other Revascularization_CPT | active | 2023-09 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.559 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.560 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_HCPCS | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.561 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD10PCS | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.562 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_ICD9PCS | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.563 | PCI (Percutaneous Coronary Intervention)_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.223 | Pneumococcal Vaccine CN_HD_SNOMED | active | 2025-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.387 | Podiatry_Taxonomy | active | 2023-11 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.589 | Polypharmacy_Clinical_Grouping_Condition_ICD10 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.590 | Polypharmacy_Clinical_Grouping_Condition_ICD9 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.591 | Polypharmacy_Clinical_Grouping_Condition_SNOMED | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.592 | Polypharmacy_Clinical_Grouping_Condition_LOINC | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.525 | Postpartum_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.526 | Postpartum_HCPCS | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.527 | Postpartum_ICD10 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.528 | Postpartum_ICD9CM | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.529 | Postpartum_LOINC | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.530 | Postpartum_SNOMED | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.418 | Pre_Hypertension (Pre_HTN)_ICD10 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.419 | Pre_Hypertension (Pre_HTN)_ICD9 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.420 | Pre_Hypertension (Pre_HTN)_SNOMED | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.502 | Prediabetes_Clinical Grouping Condition_ICD10 | active | 2025-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.503 | Prediabetes_Clinical Grouping Condition_SNOMED | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.469 | Pregnancy Due Date_LOINC | active | 2024-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.254 | Pregnancy Loss_HD_SNOMED | active | 2024-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.255 | Pregnancy Loss_HD_ICD10 | active | 2024-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.479 | Prostate Cancer Screening_HD_ICD9 | active | 2025-03 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.482 | Prostate Cancer Screening_HD_Grouping | active | 2024-04 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.484 | Prostate Dysplasia_ICD10 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.486 | Prostate Dysplasia_Grouping | active | 2024-04 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.487 | Prostectomy_ICD10 | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.488 | Prostectomy_CPT | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.490 | Prostectomy_Grouping | active | 2024-04 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.494 | PSA Testing _LOINC | active | 2025-02 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.495 | PSA Testing_Grouping | active | 2024-04 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.501 | Abnormal PSA Testing _SNOMED | active | 2024-04 | us | hl7 | ||
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.463 | Second Trimester_ICD10 | active | 2024-04 | us | hl7 |